Clinical Trials Directory

Trials / Unknown

UnknownNCT03906786

Motivational Interviewing and Self-care in Type 1 Diabetes: Randomized Controlled Clinical Trial.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Hospital Universitario Insular Gran Canaria · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Type 1 diabetes requires a high level of involvement of patients to obtain good control by following complex therapeutic recommendations. Motivational Interviewing has proven to be effective in changing behaviors in sedentary people, with addictions and with obesity. Our objective is to evaluate the impact of an intervention with Motivational Interviewing in patients with type 1 diabetes, through a randomized controlled clinical trial. At least sixty patients with type 1 diabetes will be included with HbA1c\> 8% that will be randomized with a ratio of 1: 1. In the intervention group, Motivational Interviewing will be applied in the routine clinical appointments with the Endocrinologist, while the control group will receive the same visits but in a traditional way. The primary result will be self-care behaviors according to a validated questionnaire. Secondary outcomes include: HbA1c, number of hypoglycemia, motivation with self-care, self-efficacy, quality of life, compliance with patients' own objectives, lipid profile, weight and blood pressure. The professionals will be trained in Motivational Interviewing with the objective of favoring the adherence to self-care, the motivation of the patient and improving doctor-patient relationship. They will also be evaluated through a specific questionnaire.

Conditions

Interventions

TypeNameDescription
BEHAVIORALmotivational interviewingThe intervention will consist of 4 structured medical consultations in the form of a motivational interviewing compared to usual care, covering a 12-month intervention period. In both groups, the frequency of visits (c / 3 months) and the variables collected will be the same.

Timeline

Start date
2019-03-07
Primary completion
2020-09-30
Completion
2020-09-30
First posted
2019-04-08
Last updated
2019-04-08

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03906786. Inclusion in this directory is not an endorsement.